brazil
Home
Welcome Note
Congress Chairpersons
Organizing Committee
Faculty
Scientific Program
Industry Symposia and Activities
Programa Científico
Abstract Submission
Poster Presentation Guidelines
Poster List
Timetable
CME Accreditation
Registration
Invitation Letter
Accommodation
Hard Rock Hotel Panama Megapolis
Support & Exhibition
Information
Supporters
Exhibitors
General Information
Before you travel...
Italian Agent
Tourism in Panama
About Panama
Panama Photo Gallery
Panama Video Gallery
Previous and upcoming CODHy Congresses
Partners
Useful links
Contact Us
  Poster List Print

Board #

DIABETES CARE

1

2

3

EVALUATING THE MANAGEMENT OF TYPE 2 DIABETES IN THE PRIMARY CARE SETTING THROUGH A NOVEL MULTI-STEP NEEDS ASSESSMENT PROCESS
K. Bowering1, S. Harris2, L. Leiter3, V. Woo4, J.F. Yale5
1
Medicine, Division of Endocrinology and Metabolism, University of Alberta, Canada
2
Family Medicine, Western University, Canada
3
Medicine and Nutritional Sciences, University of Toronto, Canada
4
Medicine, Section of Endocrinology and Metabolism, University of Manitoba, Canada
5Medicine, Division of Endocrinology and Metabolism, McGill University, Canada

4

HEALTH STATUS OF OLDER ADULTS RECEIVING AMBULATORY HEALTH CARE AT CAÑAZAS HOSPITAL, PROVINCE OF VERAGUAS, PANAMA
L. Cornejo1,3, C. Garcia1, O. Bermudez2,
1
Public Health, Harvard Pilgrim Health Care Institute, USA
2
Public Health, Tufts University, USA
3School of Medicine, University of Panama, Panama

5

PREDICTING FACTORSFOR IPRO CGM RECORDING PROBLEMS
I. Daskalova, T. Totomirova
Clinic of Endocrinology and metabolism, Military Medical Academy, Bulgaria

6

UNPROTECTED SUN EXPOSURE IS ASSOCIATED WITH INCREAED RISK OF DIABETES IN KOREAN ADULTS
G. Eun Gyoung1, H.S. Kwon2, J. Lee3, S.A. Chang2, B.Y. Cha2
1
Internal Medicine, Hallym University, South Korea
2
Internal Medicine, The Catholic University of Korea, South Korea
3Internal Medicine, Catholic University of Daegu, South Korea

7

UNMET NEED IN INSULIN NAIVE TYPE 2 IN LATIN AMERICAN PATIENTS
J.J. Gagliardino1, M. Tambascia2, J. de Luca
3
1
BSAS, Cenexa, Argentina
2
Endocrine Service, University of Campinas, Brazil
3BSAS, Sanofi LATAM, Argentina

8

DİAGNOSİS, TREATMENT AND FOLLOW UP OF THE PATİENTS WHO APPLİED TO MALATYA STATE HOSPİTAL WITH GESTATİONAL DIABETES
L. Keskin1, O. Nalbantoglu Elmas2, I. Pembegul Yıgıt3, Z. Kalı4, I. Ozer4
1
Endocrıne And Metabolısm Clınıc, Malatya State Hospital, Turkey
2
Pediatric Endocrine clinic, Malatya State Hospital, Turkey
3
Nephrology and Hypertension clinic, Malatya State Hospital, Turkey
4Obstetrics and Gynecology clinic, Malatya State Hospital, Turkey

9

DIABETES AWARENESS CAMPAIGN ON A PRIVATE HOSPITAL OF THE CITY OF SÃO PAULO - BRAZIL
J.M Pescuma1, A. Severine1, A. Chalhoub1, A. Yamaguti1, C. Sobral2, C. Cozer2,
D. Iezzi2, E. Suiter1, D. Krokoscz3, J. Mattar Jr2, J. Marcondes2, L. Freitas3
1
Nutrition, Hospital Sírio Libanês, Brazil
2
Medical, Hospital Sírio Libanês, Brazil
3Nursing, Hospital Sírio Libanês, Brazil

10

PRIMARY CARE VISITS OF DIABETES MELLITUS PATIENTS: WHAT PARTOF OUR WORK HAVE WE DEVOTED TO THEIR CARE IN ISRAEL-2013?
S. Sigalat, I. Marom, K. Karkabi
The Department of Family Medicine, Clalit Health Services,Haifa and Western Galilee District. The Ruth & Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Israel

11

BALANCING DIABETES AT A PRIMARY CARE CLINIC WITH A MULTIDISCIPLINARY STAFF
R. Steinberg, A. Glazer
Primary Care, Kupat Holim Maccabi, Israel
   

Board #

TYPE 1 DIABETES

12

PARTIAL REMISSION PHASE AND METABOLIC CONTROL IN TYPE 1 DIABETES MELLITUS IN CHILDREN AND ADOLESCENTS
A. Buyukgebiz1, B. Ece2
1
0-18 Klinik, Pediatric Endocrinology, Turkey
2Dokuz Eylul University, Pediatric Endocrinology, Turkey

13

C. Candelas5, M. Vidrio6
1
Nutrition Department, Hospital de Pediatría J P Garrahan, Argentina
2
Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, USA
3
Global Diabetes Division, Sanofi, France
4
Latin American Medical Department, Sanofi, Argentina
5
Clinical Sciences and Operations, Sanofi, France
6Endocrinology Department, Hospital Regional 110 IMSS, Mexico

14

ACTIVATION OF LIPOLYSIS AS A KEY MECHANISM FOR CHANGING THE FATTY ACID COMPOSITION OF BLOOD PLASMA IN CHRONIC COMPLICATIONS OF TYPE 1 DIABETES MELLITUS
A. Osipenko1, 3, D. Orlov2,
1
Resource Center, A.A. Kuleshov Mogilev State University, Belarus
2Consultative Clinic, Mogilev Regional Children's Hospital, Belarus 31st department of pathology, Mogilev Regional Autopsy Office, Belarus
   

Board #

DIABETES COMPLICATIONS

15

CARDIAC FIBROSIS PROGRESSION, TGFβ EXPRESSION AND THEIR CORRELATION WITH SERUM ADVANCED GLYCATION END PRODUCTS IN DIABETIC RATS
A. Guadrón Llanos1,4, A. Vazquez Alvarez1, A. Sobrevilla Navarro2, A. Salazar Montes2, J. Armendáriz Borunda2,
E. Cardona Muñoz3, A. Rincón Sánchez2, M. Islas Carbajal
3
1
Doctorado en Farmacología, Universidad de Guadalajara/Centro Universitario de Ciencias de la Salud, Mexico
2
Departamento de Biología Molecular y Genómica, Universidad de Guadalajara/Centro Universitario de Ciencias de la Salud, Mexico
3Departamento de Fisiología/Unidad de Investigación Cardiovascular, Universidad de Guadalajara/Centro Universitario de Ciencias de la Salud, Mexico 4Facultad de Medicina, Universidad Autonoma de Sinaloa, Mexico

16

THE ECONOMIC BURDEN OF DIABETIC PERIPHERAL NEUROPATHY IN KOREA
L. Jihyun1, H.S. Kwon2, E.G. Hong3, S.A. Chang2, B.Y. Cha2
1
Internal Medicine, Catholic University of Daegu, South Korea
2
Internal Medicine, The Catholic University of Korea, South Korea
3Internal Medicine, Hallym University, South Korea

17

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR DISEASES IN TYPE 2 DIABETICS
I. Karachentsev, A. Cherniaieva
Department of Clinical Endocrinology, State Institution ”V. Danilevsky Institute for endocrine pathology problems National Academy of Medical sciences of Ukraine”, Ukraine

18

DIENE CONJUGATES AS A STAGE MARKER OF NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETICS
N. Kravchun, H. Dorosh
Department of Pharmacotherapy of Endocrine Diseases, State Institution ”V. Danilevsky Institute for endocrine pathology problems National Academy of Medical sciences of Ukraine”, Ukraine

19

BETA 2 MICROGLOBULIN AND SUBCLINICAL ATHEROSCLEROSIS IN TYPE 2 DIABETES MELLITUS WITHOUT RENAL IMPAIRMENT
H.S. Kwon1, J. Lee2, E.G. Hong3, B.Y. Cha1, S.A. Chang1
1
Internal Medicine, The Catholic University of Korea, South Korea
2
Internal Medicine, Catholic University of Daegu, South Korea
3Internal Medicine, Hallym University, South Korea

20

SMALL DENSE LDL IS CLOSELY RELATED TO DIABETIC NEPHROPATHY IN WOMEN WITH TYPE 2 DIABETES MELLITUS
H.S. Kwon1, J. Lee2, E.G. Hong3, S.A. Chang1, B.Y. Cha1
1
Internal Medicine, The Catholic University of Korea, South Korea
2
Internal Medicine, Catholic University of Daegu, South Korea
3Internal Medicine, Hallym University, South Korea

21

EPICARDIAL ADIPOSE TISSUE IN PATIENTS WITH PROLACTINOMA
M. Unubol1, L. Bekar2, M. Katar3, A. Orhan Çelik
4
1
Department of Internal Medicine, Division of Endocrinology, Tokat State Hospital, Turkey
2
Department of Cardiology, Tokat State Hospital, Turkey
3
Department of Biochemistry, Tokat State Hospital, Turkey
4Department of Radiology, Tokat State Hospital, Turkey

22

HEPATITIS B AND C INFECTIONS FREQUENCY OF TYPE-II DIABETES MELLITUS PATIENTS IN TURKISH POPULATION
B. Acar1, M. Ünübol2, V. Yazak3, T. Gün4

1
Department of Internal Medicine, Cankiri State Hospital, Turkey
2
Department of Internal Medicine, Division of Endocrinology, Tokat State Hospital, Turkey
3
Department of Internal Medicine, Bozdogan State Hospital, Turkey
4Department of Internal Medicine, Korkuteli State Hospital, Turkey

70

F. Sarac1, A.P. Tutuncuoglu 2, S. Savas1, F. Akcicek1
1Department of Geriatrics Medicine, EgeUniversity Medical Faculty, IZMIR, Turkey
2Department of Endocrinology, Atatürk Training and Research Hospital, IZMIR, Turkey

71

A.P. Tutuncuoglu 2, F. Sarac1, S. Savas1, F. Akcicek1, A. Atmaca3
1geriatry, Ege Universitesi, ızmır, Turkey
2Endocrınology, Ataturk reseach hospıtal, Izmir, Turkey
3Endocrınology, Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Samsun, Turkey
   

Board#

EPIDEMIOLOGY

23

THE RELATION BETWEEN POSTPRANDIAL PLASMA GLUCOSE AND A1C LEVELS
A. Atmaca, G. Ecemis
Endocrinology and Metabolism, Ondokuz Mayis University, Samsun, Turkey

24

CARDIOVASCULAR COMPLICATION RISK ASSESSMENT WITH LDL-C/APO B AND HDL-C/APO A1 RATIOS IN TYPE 2 DIABETES MELLITUS PATIENTS
A. Gedikbasi1, S. Tekin Neijmann1, N. Isiksacan1, A. Kural1, N. Kocamaz
2
1
Biochemistry, Bakirkoy Dr.Sadi Konuk Traning Hospital, Turkey
2Internal Medicine, Bakirkoy Dr.Sadi Konuk Traning Hospital, Turkey

25

LDL/APO B AND HDL/APO A1 RATIOS IN DIABETES MELLITUS AND IMPAIRED FASTING GLYCAEMIA PATIENTS
A. Gedikbasi1, N. Isiksacan1, S. Tekin Neijman1, A. Kural1, N. Kocamaz2, M. Koser
3
1
Biochemistry, Bakırkoy Dr.Sadi Konuk Training and Research Hospital, Turkey
2
Internal Medicine, Bakırkoy Dr.Sadi Konuk Training and Research Hospital, Turkey
3Biochemistry, Istanbul Mehmet Akif Ersoy Thoracic & Cardiovascular Surgery Training and Research Hospital, Turkey

26

DIABETES MELLITUS IN COLOMBIA: A VIEW FROM THE REPORTING OF OFFICIAL INFORMATION SOURCES
D. Tamayo, N. Barengo, T. Tono
Research Unit - Diabetes Observatory of Colombia (Unidad de Investigación - Observatorio de Diabetes de Colombia), Health Excellence Organization (Organización para la Excelencia de la Salud), Colombia
   

Board#

DIABETIC FOOT

27

G. Porras Cortés1,4
1
Diabetes Clinic, Hospital Metropolitano Vivian Pellas, Nicaragua
2
School of Medicine, Universidad Americana, Nicaragua
3
Orthopedics Clinic, Hospital Metropolitano Vivian Pellas, Nicaragua
4Infectious Diseases Department, Hospital Metropolitano Vivian Pellas, Nicaragua

28

EPIDERMIC GROWTH FACTOR, A NEW TOOL IN HEALING DIABETIC FOOT COMPLICATEIONS
R. Rafael, M. Carrió, R. Saurral, A. Avendaño, R. Pool, D. Fernandez
Malvinas Argentinas, Center of Diabetes "Dr. A. Maggio", Argentina

29

RISK FACTORS AND CLINICAL FEATURES OF PATIENTS CONSULTED IN DIABETIC FOOT UNIT
R. Rafael, M. Carrió, R. Saurral, A. Avendaño, R. Pool
Buenos Aires, Center of Diabetes "Dr. A. Maggio", Argentina

69

A.P. Tutuncuoglu1, S. Akcay2, M. Bahceci1
1 Endocrinology, Ataturk Training and Research Hospital, IZMIR, Turkey
2 Orthopedy, Ataturk Training and Research Hospital, IZMIR, Turkey
 

 

Board#

DIABETES THERAPY

30

BASELINE BODY MASS INDEX (BMI) DOES NOT INFLUENCE THE HBA1C-LOWERING EFFICACY OF LIRAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES
E. Montanya1, V. Fonseca2, S. Colagiuri3, L. Blonde4, C. Svendsen5, S. Christensen5, M. Nauck
6
1
Endocrine Unit, Hospital Universitari Bellvitge-IDIBELL, Spain
2
Section of Endocrinology, Tulane University Medical School, USA
3
Boden Institute of Obesity, Nutrition, Exercise and Eating Disorders, University of Sydney, Australia
4
Department of Endocrinology, Diabetes and Metabolism, Ochsner Medical Center, USA
5
Medical Affairs, GLP-1 Diabetes, Novo Nordisk A/S, Denmark
6Diabetes Center, Diabeteszentrum, Germany

31

GREATER PPG CONTROL ACROSS ALL THREE MAIN MEALS WITH LIRAGLUTIDE VS PLACEBO, WHEN ADDED ON TO METFORMIN AND ROSIGLITAZONE
M. Shomali1, L. Blonde2, B. Bode3, C. Svendsen4, S. Christensen4, B. Zinman
5
1The Diabetes and Endocrine Center, MedStar Union Memorial Hospital, USA 2
Department of Endocrinology, Ochsner Medical Center, USA
3
Diabetes, Atlanta Diabetes Associates, USA
4
Medical Affairs, GLP-1 Diabetes, Novo Nordisk A/S, Denmark
5Leadership Sinai Centre for Diabetes, University of Toronto, Canada

32

IMPROVEMENTS IN HBA1C AND BODY WEIGHT WITH LIRAGLUTIDE ARE LARGELY INDEPENDENT OF DIABETES DURATION
J. Seufert1, T. Bailey2, C. Svendsen3, S. Christensen3, M. Nauck
4
1
Division of Endocrinology and Diabetology, University Hospital of Freiburg, Germany
2Endocrinology, Advanced Metabolic Care & Research (AMCR) Institute, USA 3
Medical Affairs, GLP-1 Diabetes, Novo Nordisk, Denmark
4Diabetes, Diabeteszentrum, Germany

33

ROBUST METABOLIC IMPROVEMENT OBSERVED WITH THE ENDOSCOPIC, DUODENAL-JEJUNAL BYPASS LINER: 12 MONTH DATA IN OBESE TYPE 2 DIABETES
R. Cohen1, E.G.H. de Moura3, K. Malomo2, A. Liao2, J.C. Tetreault2, J. Teare4, D. Maggs
2
1
The Center for the Surgical Treatment of Morbid Obesity and Metabolic Disorders, Hospital Oswaldo Cruz, Brazil
2
Clinical/Medical Affairs, GI Dynamics, USA
3
Digestive Surgery Department, University of Sao Paolo Medical School, Brazil
4Gastroenterology, Imperial College, UK

34

EFFICACY AND SAFETY OF LINAGLIPTIN IN HISPANIC/LATINO PATIENTS WITH TYPE 2 DIABETES: POOLED ANALYSIS FROM SIX RANDOMIZED PHASE 3 TRIALS
J. Davidson
1, R. Lajara2, R. Aguilar3, M. Mattheus4, M. von Eynatten
5
1
Internal Medicine, University of Texas Southwestern Medical Center, USA
2
Health Center at Plano, Diabetes America, USA
3
Diabetes Nation, Diabetes Nation, USA
4
Data Management, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
5Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc., USA

35

SAFETY AND EFFECTIVENESS OF SWITCHING TO ONCE-DAILY INSULIN DETEMIR IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH ONCE- OR TWICE-DAILY INSULIN GLARGINE OR NPH
G. González Galvez1, M. Arreola2, G. Dieuzeide3, L. Zajdenverg4
1
Diabetes and Obesity, Instituto Jalisciense de Investigación en Diabetes y Obesidad, Mexico
2
Medical, Novo Nordisk CLAT, Mexico
3Centro de Atención Integral en Diabetes, Endocrinología y Metabolismo, Hospital Municipal "Nuestra Sra. del Carmen de Chacabuco”, Argentina 4Internal Medicine Department/Nutrology and Diabetes Program, Hospital Universitário Clementino Fraga Filho, Federal University of Rio de Janeiro (UFRJ), Brazil

36

EFFECT OF LINAGLIPTIN VS. METFORMIN ON INSULIN SECRETION, INSULIN SENSITIVITY AND GLUCOSE CONTROL IN GLUCOSE INTOLERANCE PATIENTS
M. González Ortiz
, D.M. Hernández Corona, T. González Heredia, E. Martínez Abundis
Institute Experimental and Clinical Therapeutic, University of Guadalajara, Mexico

37

EFFECT OF RESVERATROL ADMINISTRATION ON METABOLIC SYNDROME, INSULIN SENSITIVITY AND INSULIN SECRETION
M. González Ortiz, M. Méndez del Villar, K.G. Pérez Rubio, J.R. Lizárraga Valdez
Institute Experimental and Clinical Therapeutic, University of Guadalajara, Mexico

38

ERRONEOUS DRUG CONSUMPTION AMONG OLDER PATIENTS
Y. Bar Dayan1, T. Shotashvily2, M. Boaz3, J. Wainstein4, A. Halabe4
1
Diabetes Unit, Sackler Faculty of Medicine, Wolfson Medical Center, Tel Aviv University, Israel
2Department of Medicine, Wolfson Medical Center, Israel
3
Epidemiology and Research Unit, Sackler Faculty of Medicine, Wolfson Medical Center, Tel Aviv University, Israel
4Diabetes Unit, Sackler Faculty of Medicine, Wolfson Medical Center, Tel Aviv University, Israel

39

NEW INSULIN GLARGINE U300: GLYCAEMIC CONTROL AND HYPOGLYCAEMIA IN TYPE 2 DIABETES USING A MEALTIME+BASAL INSULIN REGIMEN (EDITION 1)
P. Home
1, G.B. Bolli2, M. Ziemen3, I. Muehlen Bartmer3, F. Bizet4, M.C. Riddle
5
1
Institute of Cellular Medicine - Diabetes, Newcastle University, UK
2
Medicine, University of Perugia, Italy
3
Research and Development, Sanofi-Aventis Deutschland GmbH, Germany
4
Research and Development, Sanofi, France
5Endocrinology, Diabetes, & Clinical Nutrition, Oregon Health & Science University, USA

40

SAFETY AND EFFECTIVENESS OF MORNING VERSUS EVENING ADMINISTRATION OF ONCE-DAILY INSULIN DETEMIR IN PEOPLE WITH TYPE 2 DIABETES: OUTCOMES FROM THE A1CHIEVE STUDY
P. Home1, F.J Lavelle González2, V. Prusty3, J. Haddad
4
1
Institute of Cellular Medicine – Diabetes, Newcastle University, UK
2
Endocrinology Division, Internal Medicine Department, "Dr. José E. González” University Hospital and Medical School of the Universidad Autónoma de Nuevo León, Mexico
3
IO Medical, Novo Nordisk Region International Operations A/S, Switzerland
4Division of Endocrinology, Prince Hamazeh Hospital, Jordan

41

NEW INSULIN U300: GLUCOSE CONTROL AND HYPOGLYCAEMIA IN TYPE 2 DIABETES PEOPLE ON BASAL INSULIN AND OADS (EDITION 2)
R.M. Bergenstal1, F.J. Lavalle González2, M.C. Riddle3, M. Ziemen4, M. Wardecki5, I. Muehlen Bartmer6, E. Boelle6,
H. Yki Järvinen
7
1
International Diabetes Center, Park Nicollet Institute, USA
2
Endocrinology and Internal Medicine Department, Universidad Autonóma de Nuevo León, Mexico
3
Endocrinology, Diabetes, & Clinical Nutrition, Oregon Health & Science University, USA
4
Research and Development, Sanofi-Aventis Deutschland GmbH, Germany
5
Research and Development, Sanofi, Poland
6
Research and Development, Sanofi, France
7Division of Diabetes, University of Helsinki, Faculty of Medicine and Helsinki University Central Hospital, Finland

42

SAFETY AND EFFECTIVENESS OF SWITCHING ONCE-DAILY BASAL INSULIN (NPH OR GLARGINE) TO ONCE-DAILY BIPHASIC INSULIN ASPART 30: RESULTS FROM THE A1CHIEVE STUDY
K. Feriz1, S. B. Katz2, L. Litwak3, M. Khamseh
4
1
Endocrinology-Internal Medicine, Fundación Clínica Valle del Lili, Colombia
2
Medical Affairs, Novo Nordisk Pharma, Argentina
3Sección Diabetes y Metabolismo del Servicio de Endocrinología, Metabolismo y Medicina Nuclear, Hospital Italiano de Buenos Aires, Argentina 4Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Iran

43

EFFECT OF EXENATIDE ADMINISTERED IN DIFFERENT TIMES OF FOOD INTAKE ON GLYCEMIC CONTROL AND VARIABILITY IN PATIENTS WITH DIABETES MELLITUS TYPE 2
E. Martínez Abundis, M. González Ortiz, T. González Heredia, K.G. Pérez Rubio Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Mexico

44

FERRIC CITRATE AS A PHOSPHATE BINDER MAY OFFER BETTER GLUCOSE CONTROL IN DIALYSIS PATIENTS
R. Niecestro
1, A. Niecestro
2
1
Clinical Development, AccelaPHARM, USA
2Clinical Development, AccelaPHARM, USA

45

LIRAGLUTIDE IN COMBINATION WITH METFORMIN PROVIDES GREATER POSTPRANDIAL GLUCOSE (PPG) CONTROL VS METFORMIN MONOTHERAPY ACROSS ALL THREE MAIN MEALS
C. Olimpo Mendivil1, D.R. Matthews2, M.A. Nauck3, G. Fulcher4, L.P. Prada Romero5, S. Christensen6, A. Garber
7
1
Facultad de Medicina, Universidad de los Andes Medical School, Colombia
2
Oxford Centre for Diabetes, Endocrinology & Metabolism, The Churchill Hospital, UK
3
Diabetes, Diabeteszentrum, Germany
4
Medicine, Northern Clinical School, Australia
5
Diabetes, Novo Nordisk Pharma, Colombia
6
Medical Affairs, GLP-1 Diabetes, Novo Nordisk A/S, Denmark
7Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, USA

46

LIRAGLUTIDE MONOTHERAPY PROVIDES SUPERIOR POSTPRANDIAL PLASMA GLUCOSE (PPG) CONTROL AFTER ALL THREE DAILY MEALS VERSUS SULPHONYLUREA MONOTHERAPY
A. Palacio Barrientos1, T. Bailey2, B. Bode3, J.A. Escobar Marulanda4, S. Christensen5, A. Garber
6
1
Endocrinology, Clinicà Las Americàs, Colombia
2Endocrinology, Advanced Metabolic Care + Research (AMCR) Institute, USA 3
Diabetes, Atlanta Diabetes Associates, USA
4
Diabetes, Novo Nordisk Pharma, Colombia
5
Medical Affairs, GLP-1 Diabetes, Novo Nordisk A/S, Denmark
6Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, USA

47

THE EFFECTS OF SHORT-TERM METFORMIN TREATMENT ON VITAMIN B12 LEVELS IN NEWLY DIAGNOSED TYPE 2 DIABETIC PATIENTS
I. Sahin1, Z. Karaca1, C. Taskapan2, F. Ozyalın2, S. Yologlu
3
1Endocrinology and Metabolism, Inonu University, Turkey 2Biochemistry, İnonu University, Turkey 3Biostatistics, İnonu University, Turkey

48

DIFFERENTIAL MORNING VS. EVENING INSULIN AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RESPONSES AFTER IDENTICAL MEAL IN TYPE 2 DIABETIC SUBJECTS
J. Wainstein1,
H. Rabinovitz1, D. Jakubowicz1, Y. Bar Dayan1, O. Froy2,
1
Diabetes Unit, Wolfson Med Center Tel Aviv University, Israel
2Nutrigenomics, The Hebrew University of Jerusalem, Israel

49

PRE-MEAL CONSUMPTION OF WHEY PROTEIN ENHANCES INTACT AND TOTAL GLUCAGON–LIKE PEPTIDE-1 AND INSULIN POSTPRANDIAL RESPONSES IN TYPE 2 DIABETES
J. Wainstein1, O. Froy2, T. Ganz1, Z. Landau1, Y. Bar-Dayan1, M Barnea2, M. Menaged1, D. Jakubowicz1
1Diabetes Unit, Wolfson Med Center Tel Aviv University, Israel
2Nutrigenomics, The Hebrew University of Jerusalem, Israel
   

Board#

DIABETES THERAPY (SPANISH)

50

CONSENSOS Y CONTROVERSIAS EN TERAPIAS CONGLIPTINAS: ESTUDIO SAVOR
M. Montecinos1, V. Camaniero
2
1
Fisiopatologia, Escuela de Obstetricia, Facultad de Medicina, Universidad Diego Portales, Chile
2Diabetologia, Integramedica La Florida, Chile
   

Board#

DIET

51

AN ITALIAN OBESITY PREVENTION INTERVENTION STUDY IN TEENAGERS: THE EAT PROJECT (EFFECTIVENESS OF A SCHOOL-BASED PROGRAM ON MEASURES OF FATNESS AND BEHAVIOUR OVER 2 SCHOOL YEARS).
A.E. Malavazos1, S. Briganti1, F. Ermetici1, R. Zelaschi1, G. Pelissero2, L. Morricone
1
1
Diabetology and Metabolic Diseases Unit, IRCCS Policlinico San Donato, Italy
2Scientific Direction, IRCCS Policlinico San Donato, Italy

72

J. Jimenez, L. Fonseca, D. Chavarría, T. Gamboa
Departamento de Investigación, Universidad de Ciencias Médicas, Costa Rica
   

Board#

DIET (SPANISH)

52

CIRCUNFERENCIA DE CINTURA Y SU ASOCIACIÓN CON RIESGO CARDIOVASCULAR EN ADULTOS MAYORES CON DIABETES E HIPERTENSIÓN
H. White
, L. Marín León
Salud Colectiva- Faculdad de Ciencias Médicas, Universidad Estadual de Campinas, Brazil

74

E. Cabrera Rode, J. Rodríguez Acosta, S. E. Turcios Tristá, J. Hernández Rodríguez, R. Olano Justiniani, A. Alvarez Alvarez, J. D. Reyes, I. Cubas Dueñas, A. Hernández Yero, O. Díaz Díaz
Departamentos Inmunología-Diabetes-Bioquímica, Instituto Nacional de Endocrinologia, Cuba

75

E. Cabrera Rode, V. Rodríguez Camerón, S. E. Turcios Tristá, S. E. Lezcano Rodríguez, J. Rodríguez Acosta, N. Orlandi, R. Echavarría, A. Alvarez Alvarez, O. Díaz Díaz
Departamentos Inmunología-Endocrinología-Diabetes-Bioquímica, Instituto Nacional de Endocrinología, Cuba
   

Board#

HYPERTENSION

53

INTRADIALYTIC HYPERTENSION / HYPOTENSION AND MORTALITY IN SAN JUAN, PUERTO RICO
H. Diaz1, J. Bryan1, J. Betancourt2, J. Arraut, I. Ocasio2, J.L. Cangiano2
1
Internal Medicine, University of Puerto Rico, Puerto Rico
2Nephrology, University of Puerto Rico, Puerto Rico

54

PREVALENCE OF DYSGLYCEMIA AND PREDICTORS OFINCIDENT DIABETES IN TREATEDHYPERTENSIVE PATIENTS: A CROSS-SECTIONAL STUDY
K.Y. Kwon, J. H. Kim1, Y.S. Kim1, M.M. Lee1, M.Y. Rhee1, E.J. Cho2, K.C. Sung3, M.S. Hyon
4
1
Cardiovascular Center, Dongguk University Ilsan Hospital, South Korea
2
Internal Medicine, Catholic University St. Paul Hospital, South Korea
3
Internal Medicine, Sungkyunkwan University Kangbuk Samsung Hospital, South Korea
4Internal Medicine, Soonchunhyang University Hospital, South Korea
   

Board#

METABOLIC SYNDROME

55

56

THE ROLE OF THE CYTOKINE DISBALANCE IN THE DEVELOPMENT OF THE IMMUNE SUPPRESSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
N. Kravchun
, I. Chernyavska, I. Karachentsev
Department of Pharmacotherapy of Endocrine Diseases, V. Danilevsky Institute for endocrine pathology problems National Academy of Medical sciences of Ukraine, Ukraine

57

ELEVATED ALKALINE PHOSPHATESE LEVELS ARE ASSOCIATED WITH METABOLIC SYNDROME
F. Sarac1, S. Sarac2, S. Savas1, F. Akcicek1
1Department of Geriatrics Medicine, Ege University Medical Faculty, Turkey 2Department of Cardiology, Katip Celebi University, Atatürk Training and Research Hospital, Turkey

58

METABOLIC SYNDROME FREQUENCY AND RELATINSHIP BETWEEN C REACTIVE PROTEIN AND ITS COMPONENTS IN TURKISH ELDERLY PATIENTS
F. Sarac
, S. Savas, A. Kılavuz, F. Akcicek
Department of Geriatrics Medicine, Ege University Medical Faculty, Turkey

59

A METHOD TO PURIFY APOB100 PARTICLES FROM APOB48 PARTICLES IN TRIGLYCERIDE-RICH LIPOPROTEINS (TRL)
J.M. Schwarz1,2, G.M. Jones2, C. Pullinger1, R. Caccavello2, T. Khofri2, M. Wen1,
K. Mulligan1, E. Sinclair2, A, Gugliucci2
1
Medicine, University of California San Francisco, USA
2Osteopathic Medicine, Touro University, USA

73

G Muñoz1, T Gamboa2, C Newman3, J. Jimenez2
1Redes de Apoyo en Diabetes Mellitus, Hospital San Juan de Dios, Costa Rica 2Decanatura Posgrados & Departamento de Investigación, Universidad de Ciencias Médicas, Costa Rica
3School of Medicine, Universidad de Minnessota, USA

76

THE FLUCTUATION OF ESTROGEN LEVELS AND INSULINEMIA IN WOMEN
M. Boz, C. Muderrisoglu, F. Erdenen, E. Altunoglu, C. Gur Sal, H. Polat, E. Ulgen, F. Akbas
Internal Medicine, Istanbul Training and Research Hospital, Turkey
   

Board#

METABOLIC SYNDROME (SPANISH)

60

CORRELACIÓN ENTRE OSTEOCALCINA, INSULINORRESISTENCIA Y METABOLISMO HIDROCARBONADO EN ADULTOS MAYORES CON SÍNDROME METABÓLICO
C. Musso
, E. Mingote, G. Brenta, M. Gurfinkiel, M. Martinez, A. Nepote, A. Barreto, O. Fretes, L. Schurman, C. Faingold,
C. Sedlinsky
Endocrinology, Hospital Milstein, Argentina

61

LIPODISTROFIA: DIAGNOSTICO DE UNA ENFERMEDAD CON TRASTORNOS METABÓLICOS EXTREMOS
C. Musso1, M. Tonietti2, L. Trifone2, E. Andres4, L. Major3, F. Grabois2, C. Mussin5, M. Ferraro
4
1
Endocrinology and Metabolism, U A Milstein, Argentina
2
Nutricion y diabetes, Dr R Gutierrez, Argentina
3
Nutricion y diabetes, Hospital Municipal de San Isidro, Argentina
4Nutricion y Diabetes, Hospital Dr. P Elizalde, Argentina 5Nutricion y Diabetes, Hospital Cutral Co, Argentina
   

Board#

OBESITY

62

THE FREQUENCY OF CUSHING SYNDROME IN TURKISH MORBID OBESITY PATIENTS
M. Unubol1, M. Katar2, B. Acar3, T. Yigit
4
1
Clinic of Endocrinology and Metabolism Disorders, Tokat State Hospital, Turkey
2
Clinic of Biochemistry, Tokat State Hospital, Turkey
3
Clinic of Internal Medicine, Cankiri State Hospital, Turkey
4Clinic of Internal Medicine, Tokat State Hospital, Turkey

63

THE RELATIONSHIP BETWEEN INSULIN RESISTANCE AND CAROTID ARTERY INTIMA-MEDIA THICKNESS IN OBESE AND MORBIDLY OBESE WOMEN
G. Ecemis1, H. Kahraman1, M. Nural2, H. Aslan2, A. Atmaca1
1
Endocrinology and Metabolism, Ondokuz Mayis University, Turkey
2Radiology, Ondokuz Mayis University, Turkey

64

PREGNANCY BEFORE AND AFTER BARIATRIC SURGERY
A. Cuevas1, M.M. Farias1, M. Berry1, C. Barrera2, A. Germain
2
1
Nutrition and Bariatric Surgery, Clinica Las Condes, Chile
2Ginecology, Clinica Las Condes, Chile

65

SHORT TERM SKIN REACTIONS ASSOCIATED TO SLEEVE GASTRECTOMY ON 6 PATIENTS
A. Cuevas1, M.M. Farias1, V. Alvarez1, G. Constanza2, M.L. Perez Cotapos
2
1
Nutrition and Bariatric Surgery, Clinica Las Condes, Chile
2Dermatology, Clinica Las Condes, Chile

66

PREDICTORS OF WEIGHT LOSS IN ADOLESCENTS WITH SEVERE OBESITY AND CARDIOMETABOLIC RISK FACTORS: METFORMIN VS LIFESTYLE CHANGES
R. Nieto Martínez1, M. Briceño2, M. Rivas2, E. Ugel1, C. Carrera, P. Cowan2, P. Velásquez Mieyer
2
1
Department of Physiology and Cardio-metabolic Unit, Universidad Centro-Occidental "Lisandro Alvarado” School of Medicine, Venezuela
2UT-LifeDOC, University of Tennessee Health Science Center, USA

67

THE PREVALENCE AND TRENDS OF OBESITY IN TRABZON CITY, TURKEY FROM 1999 TO 2011
I. Nuhoglu, N. Civan, M. Kocak, H. Coskun, H.O. Ersoz, C. Erem
Endocrinology and Metabolism, KTU Medical Faculty, Turkey

68

CHILDHOOD OBESITY - A NEW CHALLENGE TO THE BASIC HEALTH UNITS IN BRAZIL
P. Loredano Souza, L. Maychak, M. Ferreira
Medicine, Universidade Cidade de São Paulo, Brazil

Home    Contact Us   
 
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 01/31/2016 Created by     WebStudio.co.il